Allergic Asthma Therapeutics Market
According to Intent Market Research, the Allergic Asthma Therapeutics Market is expected to grow from USD 18.6 Billion in 2024-e at a CAGR of 9.9% to touch USD 32.7 Billion by 2030. The Allergic Asthma Therapeutics Market is dominated by key players such as, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., AstraZeneca PLC, Boehringer Ingelheim International GmbH, and Merck & Co., Inc.